Europe — EMA
Ondansetron Kabi (Ondansetron Hydrochloride Dihydrate)
GNH USA supplies Ondansetron Kabi (Ondansetron), a 5-HT3 receptor antagonist for chemotherapy, radiation and postoperative nausea.
Request sourcing
What is Ondansetron Hydrochloride Dihydrate?
Ondansetron, the active ingredient in Ondansetron Kabi, is a 5-HT3 receptor antagonist presented as a sterile injectable solution for intravenous use. It is employed to prevent and treat nausea and vomiting associated with chemotherapy, radiotherapy, and surgery in adult and pediatric patients. GNH USA supplies Ondansetron Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, and pharmacies worldwide.
What is Ondansetron Hydrochloride Dihydrate used for?
Ondansetron Kabi is a 5‑HT3 receptor antagonist used to control nausea and vomiting in several clinical settings.
- Chemotherapy‑induced nausea and vomiting: prevents acute and delayed episodes in patients receiving emetogenic chemotherapy. - Radiation‑induced nausea and vomiting: reduces symptoms during and after radiotherapy. - Postoperative nausea and vomiting: decreases incidence of nausea and vomiting following surgical procedures.
What are the side effects of Ondansetron Hydrochloride Dihydrate?
Ondansetron Kabi is generally well tolerated, but adverse reactions can occur.
Common Side Effects: - Headache: mild to moderate intensity. - Constipation: reduced bowel movements. - Dizziness: transient light‑headedness. - Fatigue: feeling of tiredness. - Diarrhoea: loose stools. - Injection site pain: mild discomfort at the site.
Serious or Rare Side Effects: - QT interval prolongation: may lead to cardiac arrhythmia. - Severe allergic reaction: rash, swelling, or anaphylaxis. - Serotonin syndrome: agitation, hyperreflexia, fever. - Cardiac arrhythmia: irregular heart rhythm. - Hepatic dysfunction: elevated liver enzymes. - Severe hypotension: marked drop in blood pressure.
What precautions apply to Ondansetron Hydrochloride Dihydrate?
When using Ondansetron Kabi, consider the following precautions.
- Cardiac risk assessment: evaluate QT prolongation risk before initiation. - Electrolyte monitoring: correct hypokalaemia or hypomagnesaemia. - Hepatic impairment: use with caution in patients with liver dysfunction. - Renal impairment: dose adjustment may be required in severe renal failure. - Hypersensitivity: discontinue if allergic reaction occurs. - Store at room temperature: keep in original container, protect from moisture and light.
What does Ondansetron Hydrochloride Dihydrate interact with?
Ondansetron Kabi may interact with other medicines; monitor accordingly.
Major Interactions (Avoid): - Apomorphine: can cause severe hypotension and loss of consciousness. - Other QT‑prolonging agents: increase risk of cardiac arrhythmia. - Tricyclic antidepressants: may enhance QT prolongation.
Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (e.g., ketoconazole): may increase ondansetron plasma levels. - Anesthetic agents (e.g., propofol): may potentiate sedative effects. - Other antiemetics (e.g., metoclopramide): may increase risk of serotonin syndrome.
